Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Efficacy and clinical determinants of antipsychotic polypharmacy in psychotic patients experiencing an acute relapse and admitted to hospital stay: results from a cross-sectional and a subsequent longitudinal pilot study.

Iasevoli F, Buonaguro EF, Marconi M, Di Giovambattista E, Rapagnani MP, De Berardis D, Martinotti G, Mazza M, Balletta R, Serroni N, Di Giannantonio M, de Bartolomeis A, Valchera A.

ISRN Pharmacol. 2014 Jan 27;2014:762127. doi: 10.1155/2014/762127. eCollection 2014.

PMID:
24592333
[PubMed]
Free PMC Article
2.

Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.

Lerma-Carrillo I, de Pablo Brühlmann S, del Pozo ML, Pascual-Pinazo F, Molina JD, Baca-García E.

Clin Neuropharmacol. 2008 Nov-Dec;31(6):319-32. doi: 10.1097/WNF.0b013e31815cba78.

PMID:
19050409
[PubMed - indexed for MEDLINE]
3.

A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.

Megna JL, Kunwar AR, Mahlotra K, Sauro MD, Devitt PJ, Rashid A.

J Psychiatr Pract. 2007 Mar;13(2):129-37.

PMID:
17414692
[PubMed - indexed for MEDLINE]
4.

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

Kane JM, Leucht S, Carpenter D, Docherty JP; Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.

J Clin Psychiatry. 2003;64 Suppl 12:5-19.

PMID:
14640142
[PubMed - indexed for MEDLINE]
5.

Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study.

Kroken RA, Johnsen E, Ruud T, Wentzel-Larsen T, Jørgensen HA.

BMC Psychiatry. 2009 May 16;9:24. doi: 10.1186/1471-244X-9-24.

PMID:
19445700
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
7.

Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.

Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.

Health Technol Assess. 2001;5(21):1-75. Review.

PMID:
11532238
[PubMed - indexed for MEDLINE]
Free Article
8.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
[PubMed - indexed for MEDLINE]
9.

Polypharmacy with second-generation antipsychotics: a review of evidence.

Pandurangi AK, Dalkilic A.

J Psychiatr Pract. 2008 Nov;14(6):345-67. doi: 10.1097/01.pra.0000341890.05383.45. Review.

PMID:
19057237
[PubMed - indexed for MEDLINE]
10.

Audit of antipsychotic prescribing in a private psychiatric hospital.

Botvinik L, Ng C, Schweitzer I.

Australas Psychiatry. 2004 Sep;12(3):227-33.

PMID:
15715780
[PubMed - indexed for MEDLINE]
11.

Antipsychotics prescribing patterns of patients with schizophrenia admitted to korean general hospital psychiatric unit: 2001 to 2008.

Choi HJ, Jung SH, Kang MH, Lee JS, Bae JN, Kim CE.

Clin Psychopharmacol Neurosci. 2011 Apr;9(1):17-22. doi: 10.9758/cpn.2011.9.1.17. Epub 2011 Apr 30.

PMID:
23430568
[PubMed]
Free PMC Article
12.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group.

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
[PubMed - indexed for MEDLINE]
13.

Long-term antipsychotic polypharmacy: how does it start, why does it continue?

Grech P, Taylor D.

Ther Adv Psychopharmacol. 2012 Feb;2(1):5-11. doi: 10.1177/2045125311430110.

PMID:
23983950
[PubMed]
Free PMC Article
14.

Determinants of antipsychotic polypharmacy in psychiatric inpatients: a prospective study.

Biancosino B, Barbui C, Marmai L, Donà S, Grassi L.

Int Clin Psychopharmacol. 2005 Nov;20(6):305-9. Erratum in: Int Clin Psychopharmacol. 2007 Mar;22(2):124. Donà, Silna [corrected to Donà, Silvia].

PMID:
16192838
[PubMed - indexed for MEDLINE]
15.

Long-term combination antipsychotic treatment in VA patients with schizophrenia.

Kreyenbuhl J, Valenstein M, McCarthy JF, Ganoczy D, Blow FC.

Schizophr Res. 2006 May;84(1):90-9. Epub 2006 May 2.

PMID:
16631354
[PubMed - indexed for MEDLINE]
16.

Effectiveness of switching from antipsychotic polypharmacy to monotherapy.

Essock SM, Schooler NR, Stroup TS, McEvoy JP, Rojas I, Jackson C, Covell NH; Schizophrenia Trials Network.

Am J Psychiatry. 2011 Jul;168(7):702-8. doi: 10.1176/appi.ajp.2011.10060908. Epub 2011 May 2.

PMID:
21536693
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder.

Elie D, Poirier M, Chianetta J, Durand M, Grégoire C, Grignon S.

J Psychopharmacol. 2010 Jul;24(7):1037-44. doi: 10.1177/0269881108100777. Epub 2009 Jan 22.

PMID:
19164494
[PubMed - indexed for MEDLINE]
18.

Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.

Kreyenbuhl JA, Valenstein M, McCarthy JF, Ganoczy D, Blow FC.

Psychiatr Serv. 2007 Apr;58(4):489-95.

PMID:
17412850
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Use of atypical antipsychotic medications in adolescent psychiatric inpatients: a comparison with inpatients who did not receive antipsychotic medications during their stay.

Pogge DL, Young K, Insalaco B, Harvey PD.

Int J Clin Pract. 2007 Jun;61(6):896-902.

PMID:
17504351
[PubMed - indexed for MEDLINE]
20.

The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.

Kramer MS, Last B, Getson A, Reines SA.

Arch Gen Psychiatry. 1997 Jun;54(6):567-72. Erratum in: Arch Gen Psychiatry 1997 Dec;54(12):1080.

PMID:
9193198
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk